Recognizing the key cytokines driving type 2 inflammation and understanding their profound impact on patients’ asthma burden is crucial.^1-3

What’s New in the GOLD 2026 Report

Summary of Kuwait’s updated RSV prevention policy

Skin involvement represents the most frequent and often earliest manifestation of both acute and chronic GvHD, with significant diagnostic and therapeutic implications. In this episode, Dr. Marawan and Dr. Yousef provide a comprehensive, multidisciplinary review of clinical presentation, differential diagnosis, histopathologic correlation, NIH grading criteria, and the functional and quality-of-life impact of cutaneous GvHD. The discussion also addresses challenges in distinguishing chronic skin GvHD from autoimmune mimickers and highlights the importance of early recognition and coordinated care to optimize patient outcomes.

The congress connection: CGvHD and Transplant Key Takeaways in 2026

Pulmonary involvement in chronic Graft-versus-Host Disease (cGvHD) is a serious and often underrecognized complication that can significantly impact long-term outcomes following allogeneic stem cell transplantation. In this episode, Dr. Marawan and Dr. Rayid provide a multidisciplinary perspective on the recognition, diagnosis, and management of pulmonary cGvHD. Through expert discussion, they highlight the critical role of proactive screening, early identification of symptoms, timely referral, and close collaboration between hematologists and pulmonologists to prevent irreversible lung damage.

Eosinophilic inflammation has multiple drivers^1,2